Insider filing · IMVT
Eric Venker
President & Immunovant CEO
profile →
Immunovant, Inc.
IMVT · Healthcare · 35 filings in 24 months
ticker →
Eric Venker sold $308K of Immunovant (IMVT)
Executed Apr 2, disclosed Apr 3, 1 day later.
Value, as filed
$308K
12,820 sh × $24.04
Executed
Apr 2
the trade date, as filed
Disclosed
Apr 3
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EVEric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $14.5M of ROIV (851,383 sh across 3 lots, as filed), executed Oct 15 2025.
The name
IMVTHealthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Eric Venker in IMVT
IMVTSALE
Immunovant, Inc.
$119K3,092 sh × $38.48
Exec Jul 2
Filed Jul 6 · 5:01 PM ET